185 related articles for article (PubMed ID: 31701679)
1. Connect MM Registry as a national reference for United States multiple myeloma patients.
Ailawadhi S; Jagannath S; Narang M; Rifkin RM; Terebelo HR; Toomey K; Durie BGM; Hardin JW; Gasparetto CJ; Wagner L; Omel JL; Kumar V; Yue L; Kitali A; Agarwal A; Abonour R;
Cancer Med; 2020 Jan; 9(1):35-42. PubMed ID: 31701679
[TBL] [Abstract][Full Text] [Related]
2. Impact of access to NCI- and NCCN-designated cancer centers on outcomes for multiple myeloma patients: A SEER registry analysis.
Ailawadhi S; Advani P; Yang D; Ghosh R; Swaika A; Roy V; Foran J; Colon-Otero G; Chanan-Khan A
Cancer; 2016 Feb; 122(4):618-25. PubMed ID: 26565660
[TBL] [Abstract][Full Text] [Related]
3. A Comparison of the NCDB and SEER Database for Research Involving Head and Neck Cancer.
Janz TA; Graboyes EM; Nguyen SA; Ellis MA; Neskey DM; Harruff EE; Lentsch EJ
Otolaryngol Head Neck Surg; 2019 Feb; 160(2):284-294. PubMed ID: 30129822
[TBL] [Abstract][Full Text] [Related]
4. Plasma Cell Myeloma - 20-Year Comparative Survival and Mortality of Three Plasma Cell Myeloma ICD-O-3 Oncologic Phenotypes by Age, Sex, Race, Stage, Cohort Entry Time-Period and Disease Duration: A Systematic Review of 111,041 Cases for Diagnosis Years 1973-2014: (SEER*Stat 8.3.4).
Milano AF
J Insur Med; 2018; 47(4):203-211. PubMed ID: 30668210
[TBL] [Abstract][Full Text] [Related]
5. Multiple myeloma incidence, mortality, and survival differences at the intersection of sex, age, and race/ethnicity: A comparison between Puerto Rico and the United States SEER population.
Castañeda-Avila MA; Suárez-Ramos T; Torres-Cintrón CR; Epstein MM; Gierbolini-Bermúdez A; Tortolero-Luna G; Ortiz-Ortiz KJ
Cancer Epidemiol; 2024 Apr; 89():102537. PubMed ID: 38295555
[TBL] [Abstract][Full Text] [Related]
6. Trends in cause of death among patients with multiple myeloma in Puerto Rico and the United States SEER population, 1987-2013.
Castañeda-Avila MA; Ortiz-Ortiz KJ; Torres-Cintrón CR; Birmann BM; Epstein MM
Int J Cancer; 2020 Jan; 146(1):35-43. PubMed ID: 30802944
[TBL] [Abstract][Full Text] [Related]
7. Treatment Outcomes and Health Care Resource Utilization in Patients With Newly Diagnosed Multiple Myeloma Receiving Lenalidomide-only Maintenance, Any Maintenance, or No Maintenance: Results from the Connect MM Registry.
Rifkin RM; Jagannath S; Durie BGM; Narang M; Terebelo HR; Gasparetto CJ; Toomey K; Hardin JW; Wagner L; Parikh K; Abouzaid S; Srinivasan S; Kitali A; Zafar F; Abonour R
Clin Ther; 2018 Jul; 40(7):1193-1202.e1. PubMed ID: 30007443
[TBL] [Abstract][Full Text] [Related]
8. Development of a prognostic model for overall survival in multiple myeloma using the Connect
Terebelo HR; Abonour R; Gasparetto CJ; Toomey K; Durie BGM; Hardin JW; Jagannath S; Wagner L; Narang M; Flick ED; Srinivasan S; Yue L; Kitali A; Agarwal A; Rifkin RM;
Br J Haematol; 2019 Dec; 187(5):602-614. PubMed ID: 31382320
[TBL] [Abstract][Full Text] [Related]
9. Survival Analyses and Prognosis of Plasma-Cell Myeloma and Plasmacytoma-Like Posttransplantation Lymphoproliferative Disorders.
Rosenberg AS; Ruthazer R; Paulus JK; Kent DM; Evens AM; Klein AK
Clin Lymphoma Myeloma Leuk; 2016 Dec; 16(12):684-692.e3. PubMed ID: 27771291
[TBL] [Abstract][Full Text] [Related]
10. Merging claims databases with a tumor registry to evaluate variations in cancer mortality: results from a pilot study of 698 colorectal cancer patients treated at one hospital in the 1990s.
Kim SP; Feinglass J; Bennett CL; Lyons T; Simon C; Weinberg MN; Talamonti MS
Cancer Invest; 2004; 22(2):225-33. PubMed ID: 15199605
[TBL] [Abstract][Full Text] [Related]
11. The National Cancer Data Base report on patterns of childhood cancers in the United States.
Grovas A; Fremgen A; Rauck A; Ruymann FB; Hutchinson CL; Winchester DP; Menck HR
Cancer; 1997 Dec; 80(12):2321-32. PubMed ID: 9404710
[TBL] [Abstract][Full Text] [Related]
12. Association between race and treatment patterns and survival outcomes in multiple myeloma: A Connect MM Registry analysis.
Ailawadhi S; Jagannath S; Lee HC; Narang M; Rifkin RM; Terebelo HR; Durie BGM; Toomey K; Hardin JW; Gasparetto CJ; Wagner L; Omel JL; He M; Yue L; Flick ED; Agarwal A; Abonour R;
Cancer; 2020 Oct; 126(19):4332-4340. PubMed ID: 32706404
[TBL] [Abstract][Full Text] [Related]
13. Epidemiological trends in 1452 cases of retinoblastoma from the Surveillance, Epidemiology, and End Results (SEER) registry.
Andreoli MT; Chau FY; Shapiro MJ; Leiderman YI
Can J Ophthalmol; 2017 Dec; 52(6):592-598. PubMed ID: 29217028
[TBL] [Abstract][Full Text] [Related]
14. Trends in multiple myeloma presentation, management, cost of care, and outcomes in the Medicare population: A comprehensive look at racial disparities.
Ailawadhi S; Frank RD; Sharma M; Menghani R; Temkit M; Paulus S; Khera N; Hashmi S; Advani P; Swaika A; Paulus A; Aslam N; Sher T; Roy V; Colon-Otero G; Chanan-Khan A
Cancer; 2018 Apr; 124(8):1710-1721. PubMed ID: 29360160
[TBL] [Abstract][Full Text] [Related]
15. Persistent socioeconomic inequalities in cancer survival in the United States: 1973-2007 surveillance, epidemiology and end results (SEER) data for breast cancer and non-Hodgkin's lymphoma.
Kato I; Booza J; Quarshie WO; Schwartz K
J Registry Manag; 2012; 39(4):158-66. PubMed ID: 23493021
[TBL] [Abstract][Full Text] [Related]
16. Survival Disparities in Multiple Myeloma by Health Insurance Status among US Non-Elderly Adults: A SEER-Based Comparative Analysis.
Huang C; Liu H; Jia L; Lu M; Hu S
Acta Haematol; 2021; 144(5):542-550. PubMed ID: 33784666
[TBL] [Abstract][Full Text] [Related]
17. Impact of age, race and decade of treatment on overall survival in a critical population analysis of 40,000 multiple myeloma patients.
Kaya H; Peressini B; Jawed I; Martincic D; Elaimy AL; Lamoreaux WT; Fairbanks RK; Weeks KA; Lee CM
Int J Hematol; 2012 Jan; 95(1):64-70. PubMed ID: 22160833
[TBL] [Abstract][Full Text] [Related]
18. Regional and racial disparity in proximal gastric cancer survival outcomes 1996-2016: Results from SEER and China National Cancer Center database.
Zhao L; Niu P; Zhao D; Chen Y
Cancer Med; 2021 Jul; 10(14):4923-4938. PubMed ID: 34105890
[TBL] [Abstract][Full Text] [Related]
19. Survival of patients with malignant primary osseous spinal neoplasms: results from the Surveillance, Epidemiology, and End Results (SEER) database from 1973 to 2003.
Mukherjee D; Chaichana KL; Gokaslan ZL; Aaronson O; Cheng JS; McGirt MJ
J Neurosurg Spine; 2011 Feb; 14(2):143-50. PubMed ID: 21184634
[TBL] [Abstract][Full Text] [Related]
20. Disparities among racial/ethnic groups of patients diagnosed with ependymoma: analyses from the Surveillance, Epidemiology and End Results (SEER) registry.
Stenzel AE; Fenstermaker RA; Wiltsie LM; Moysich KB
J Neurooncol; 2019 Aug; 144(1):43-51. PubMed ID: 31209774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
